CEO James Boyle was paid $3,860,972 in fiscal year 2025, ↓ down 10.3% from fiscal year 2024, the 1st percentile of its disclosed peer group (SEC filing 0001104659-26-047092 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
$10,907,077 James Pigott total, FY2025 President — highest-paid officer; CEO James Boyle: $3,860,972 | 1st CEO (James Boyle) pay percentile vs peers | — CEO-to-median pay ratio | 99.48% Say-on-pay support, latest vote |
You have just read Medline's Summary Compensation Table. The whole free brief as a PDF, sent in 2 minutes, with every figure cited — then a few short notes on the deeper MDLN reports.
We send the PDF within 2 minutes, then up to three short notes. Reply “unsubscribe” to any of them, any time.
Track this company's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year
Ask our research desk — $99, 24h, every figure cited to its filing.
MDLN's next annual pay disclosure, estimated April 23, 2027.est. Filing ↗
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| James Pigott | $1,100,000 | $0 | $0 | $0 | $930,573 | $0 | $8,876,504 | $10,907,077 |
| President | ||||||||
| James Boyle | 1,250,000 | 0 | 1,177,665 | 0 | 1,409,960 | 0 | 23,347 | 3,860,972 |
| Chief Executive Officer | ||||||||
| Michael Drazin | 810,000 | 0 | 956,853 | 0 | 763,117 | 0 | 27,289 | 2,557,259 |
| Chief Financial Officer | ||||||||
| Douglas Golwas | 800,000 | 0 | 956,853 | 0 | 772,410 | 0 | 25,030 | 2,554,293 |
| Chief Commercial Officer | ||||||||
| Stephen Miller | 800,000 | 0 | 956,853 | 0 | 676,781 | 0 | 9,140 | 2,442,774 |
| Chief Operating Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| James Pigott | $10,907,077 | $3,957,278 | — | ↑ +6,949,799 |
| James Boyle | 3,860,972 | 4,305,297 | — | ↓ −444,325 |
| Michael Drazin | 2,557,259 | 2,759,644 | — | ↓ −202,385 |
| Douglas Golwas | 2,554,293 | 2,758,157 | — | ↓ −203,864 |
| Stephen Miller | 2,442,774 | 4,315,145 | — | ↓ −1,872,371 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
How we handle your data → Privacy
Each company listed discloses MDLN in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named MDLN in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
One page per director: the seat, the committees and the fee table, read for one person at a time.
| Director | Role | FY2025 total |
|---|---|---|
| Anushka M. Sunder | Independent Director | — |
| Jacob D. Best | Independent Director | — |
| Joseph P. Baratta | Independent Director | — |
| Patrick J. Healy | Independent Director | — |
| Richard A. Galanti | Independent Director | $375,787 |
| Robert R. Schmidt | Independent Director | — |
| Stephen H. Wise | Independent Director | — |
| Thomas W. Sweet | Independent Director | $150,000 |
| Todd M. Bluedorn | Independent Director | $304,921 |
No insider equity transactions reported since the proxy statement.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Michael Drazin | PSU | 2025-04-11 | 16,497 | 32,995 | — | 49,492 | $956,853 |
| Douglas Golwas | PSU | 2025-04-11 | 16,497 | 32,995 | — | 49,492 | 956,853 |
| James Boyle | PSU | 2025-04-11 | 20,305 | 40,609 | — | 60,914 | 1,177,665 |
| Stephen Miller | PSU | 2025-04-11 | 16,497 | 32,995 | — | 49,492 | 956,853 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Michael Drazin | $0 | $956,853 | $0 | 100.0% |
| Douglas Golwas | 0 | 956,853 | 0 | 100.0% |
| James Boyle | 0 | 1,177,665 | 0 | 100.0% |
| Stephen Miller | 0 | 956,853 | 0 | 100.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| James Pigott | RSU | 1,008,005 | — | $18,947,619 |
| James Boyle | RSU | 799,632 | — | 11,777,744 |
| Michael Drazin | RSU | 506,913 | — | 7,848,576 |
| Douglas Golwas | RSU | 356,473 | — | 5,503,398 |
| Stephen Miller | RSU | 255,035 | — | 2,876,222 |
The compensation program is designed to enhance business strategy, attract and retain innovative business leaders, and build long-term results for stockholders.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Korn Ferry |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-11 | 1,189,280,399 | 6,203,145 | 54,988 | 99.48% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-06-11 | 99.48%a |
a. Voting standard not stated in the filing.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Richard A. GalantiIndependent | $75,787 | $300,000 | — | — | — | $375,787 |
| Todd M. BluedornIndependent | 4,921 | 300,000 | — | — | — | 304,921 |
| Thomas W. SweetIndependent | 150,000 | 0 | — | — | — | 150,000 |
| James M. BoyleEmployee director | — | — | — | — | — | 0 |
| Stephen H. WiseIndependent | — | 0 | — | — | — | — |
| Robert R. SchmidtIndependent | — | 0 | — | — | — | — |
| Charles N. MillsNot independent · Board Chair | — | — | — | — | — | — |
| Jacob D. BestIndependent | — | 0 | — | — | — | — |
| Andrew J. MillsNot independent | — | — | — | — | — | — |
| Patrick J. HealyIndependent | — | 0 | — | — | — | — |
| Anushka M. SunderIndependent | — | 0 | — | — | — | — |
| Joseph P. BarattaIndependent | — | 0 | — | — | — | — |
| Annual cash retainer | $125,000 |
|---|---|
| Annual equity retainer | $200,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 25,000 / 20,000 / 20,000 |
| Stock ownership guideline | $5 |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $230,708 |
| Equity awards (grant-date value) | $600,000 |
| All other compensation | $0 |
| Total cost of the board | $830,708 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies Medline names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Medline.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific Inc. | 2025 | Marc Casper | $1,785,534 | $65,730,211 | $7,951,377 | $3,742,123 | $79,923,350 |
| 2 | Baxter International Inc. | 2025 | Andrew Hider | 499,315 | 23,133,518 | 3,185,053 | 820,125 | 29,805,182 |
| 3 | Danaher Corporation | 2025 | Rainer Blair | 1,400,000 | 9,292,370 | 8,386,657 | 4,194,400 | 23,795,280 |
| 4 | Stryker Corporation | 2025 | Kevin Lobo | 1,500,000 | 9,764,136 | 6,920,781 | 2,250,000 | 21,401,495 |
| 5 | 3M Company | 2025 | William Brown | 1,800,000 | 7,753,852 | 7,001,242 | 3,745,322 | 21,005,009 |
| 6 | Honeywell International Inc. | 2025 | Vimal Kapur | 1,600,000 | 10,866,269 | 3,623,914 | 3,516,800 | 20,381,435 |
| 7 | GE HealthCare Technologies Inc. | 2025 | Peter Arduini | 1,324,983 | 11,249,533 | 3,624,970 | 2,081,084 | 18,562,794 |
| 8 | Becton, Dickinson and Company | 2025 | Thomas Polen | 1,395,463 | 9,991,854 | 3,311,861 | 1,852,010 | 17,129,140 |
| 9 | Colgate-Palmolive Company | 2025 | Noel Wallace | 1,500,000 | 8,005,152 | 3,570,016 | 2,455,950 | 16,478,196 |
| 10 | Kimberly-Clark Corporation | 2025 | Michael Hsu | 1,500,000 | 11,499,989 | 0 | 1,596,424 | 15,320,405 |
| 11 | Illinois Tool Works, Inc. | 2025 | Christopher A. O'Herlihy | 1,337,271 | 5,249,957 | 5,249,996 | 2,702,389 | 15,211,011 |
| 12 | Henry Schein, Inc. | 2025 | Stanley Bergman | 1,707,000 | 7,764,800 | 0 | 2,289,251 | 12,013,915 |
| 13 | W.W. Grainger, Inc. | 2025 | D.G. Macpherson | 1,176,370 | 8,451,819 | 0 | 1,653,075 | 11,609,508 |
| 14 | Medline | 2025 | James Boyle | 1,250,000 | 1,177,665 | 0 | 1,409,960 | 3,860,972 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Medline | not disclosed | not disclosed | not disclosed | Korn Ferry |
| 3M Company | 118.9% | PSU 50 · Options 50 | No | FW Cook |
| Baxter International Inc. | not disclosed | not disclosed | No | Aon Consulting, Inc. (Aon) |
| Becton, Dickinson and Company | 85% | PSU 50 · Options 25 · RSU 25 | No | Semler Brossy |
| Colgate-Palmolive Company | 93.6% | PSU 50 · Options 30 · RSU 20 | No | FW Cook |
| Danaher Corporation | not disclosed | Options 50 · RSU 50 | Yes — Relative TSR | FW Cook |
| GE HealthCare Technologies Inc. | 101% | PSU 50 · Option 25 · RSU 25 | No | Semler Brossy |
| Henry Schein, Inc. | 89.3% | PSU 65 · RSU 35 | No | Pearl Meyer |
| Honeywell International Inc. | 126% | PSU 50 · Options 25 · RSU 25 | Yes — three-year total shareowner return (TSR) relative to the 2025 Compensation Peer Group | not disclosed |
| Illinois Tool Works, Inc. | not disclosed | PSU 50 · Options 50 | No | Meridian Compensation Partners LLC |
| Kimberly-Clark Corporation | 61% | PSU 60 · RSU 40 | No | Semler Brossy Consulting Group |
| Stryker Corporation | 100% | PSU 48 · Options 34 | No | Semler Brossy |
| Thermo Fisher Scientific Inc. | 99.8% | PSU 50 · Options 50 | Yes — Relative TSR | Pearl Meyer |
| W.W. Grainger, Inc. | 93% | PSU 60 · RSU 40 | No | Pay Governance, LLC |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, James Pigott | DEF 14A | 2026-04-23 | 0001104659-26-047092 | Section “Executive Compensation Tables”. As printed: 10,907,077. Filing ↗machine: r5 · c42 · span 1447156–1447166 |
| 2 | Section 01, James Boyle | DEF 14A | 2026-04-23 | 0001104659-26-047092 | Section “Executive Compensation Tables”. As printed: 3,860,972. Filing ↗machine: r1 · c42 · span 1422792–1422801 |
| 3 | Section 01, Michael Drazin | DEF 14A | 2026-04-23 | 0001104659-26-047092 | Section “Executive Compensation Tables”. As printed: 2,557,259. Filing ↗machine: r3 · c42 · span 1434968–1434977 |
| 4 | Section 01, Douglas Golwas | DEF 14A | 2026-04-23 | 0001104659-26-047092 | Section “Executive Compensation Tables”. As printed: 2,554,293. Filing ↗machine: r7 · c42 · span 1459335–1459344 |
| 5 | Section 01, Stephen Miller | DEF 14A | 2026-04-23 | 0001104659-26-047092 | Section “Executive Compensation Tables”. As printed: 2,442,774. Filing ↗machine: r9 · c42 · span 1471430–1471439 |
| 6 | Section 03, Michael Drazin PSU | DEF 14A | 2026-04-23 | 0001104659-26-047092 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1534914–1534921 |
| 7 | Section 03, Douglas Golwas PSU | DEF 14A | 2026-04-23 | 0001104659-26-047092 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1551027–1551034 |
| 8 | Section 03, James Boyle PSU | DEF 14A | 2026-04-23 | 0001104659-26-047092 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1526182–1526191 |
| 9 | Section 03, Stephen Miller PSU | DEF 14A | 2026-04-23 | 0001104659-26-047092 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1558763–1558770 |
| 10 | Section 08, Richard A. Galanti | DEF 14A | 2026-04-23 | 0001104659-26-047092 | Section “Director Compensation”. As printed: 375,787. Filing ↗machine: span 765225–765232 |
| 11 | Section 08, Todd M. Bluedorn | DEF 14A | 2026-04-23 | 0001104659-26-047092 | Section “Director Compensation”. As printed: 304,921. Filing ↗machine: span 768048–768055 |
| 12 | Section 08, Thomas W. Sweet | DEF 14A | 2026-04-23 | 0001104659-26-047092 | Section “Director Compensation”. As printed: 150,000. Filing ↗machine: span 762105–762112 |
| 13 | Section 08, James M. Boyle | DEF 14A | 2026-04-23 | 0001104659-26-047092 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 14 | Section 08, Stephen H. Wise | DEF 14A | 2026-04-23 | 0001104659-26-047092 | Section “Director Compensation”. As printed: —. Filing ↗ |
| 15 | Section 08, Robert R. Schmidt | DEF 14A | 2026-04-23 | 0001104659-26-047092 | Section “Director Compensation”. As printed: —. Filing ↗ |
| 16 | Section 08, Charles N. Mills | DEF 14A | 2026-04-23 | 0001104659-26-047092 | Section “Director Compensation”. As printed: —. Filing ↗ |
| 17 | Section 08, Jacob D. Best | DEF 14A | 2026-04-23 | 0001104659-26-047092 | Section “Director Compensation”. As printed: —. Filing ↗ |
| 18 | Section 08, Andrew J. Mills | DEF 14A | 2026-04-23 | 0001104659-26-047092 | Section “Director Compensation”. As printed: —. Filing ↗ |
| 19 | Section 08, Patrick J. Healy | DEF 14A | 2026-04-23 | 0001104659-26-047092 | Section “Director Compensation”. As printed: —. Filing ↗ |
| 20 | Section 08, Anushka M. Sunder | DEF 14A | 2026-04-23 | 0001104659-26-047092 | Section “Director Compensation”. As printed: —. Filing ↗ |
| 21 | Section 08, Joseph P. Baratta | DEF 14A | — | — | Section “Director Compensation”. As printed: —. |
| 22 | Section 06, 2026 vote | Form 8-K | 2026-06-12 | 0002046386-26-000037 | Item 5.07 · say-on-pay result. As reported: 99.48% (votes for as printed: 1,189,280,399). Filing ↗ |
| 23 | Section 01 trend, Δ column (computed) | Computed | — | — | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 24 | Section 03b vehicle mix (computed) | Computed | — | — | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 25 | Section 09b board cost (computed) | Computed | — | — | Cash 230,708 + equity 600,000 + all other 0 = 830,708, summed across the director compensation table rows.machine: formula: Σ = 830,708 |
| 26 | Thermo Fisher Scientific Inc., Section 10b CEO total | DEF 14A | 2026-04-07 | 0001193125-26-144585 | CEO total compensation as printed in Thermo Fisher Scientific Inc.'s own proxy. As printed: 79,923,350. Filing ↗machine: span 973487–973497 |
| 27 | Baxter International Inc., Section 10b CEO total | DEF 14A | 2026-03-23 | 0001628280-26-020330 | CEO total compensation as printed in Baxter International Inc.'s own proxy. As printed: 29,805,182. Filing ↗machine: r4 · c30 · span 1451066–1451076 |
| 28 | Danaher Corporation, Section 10b CEO total | DEF 14A | 2026-03-25 | 0000313616-26-000101 | CEO total compensation as printed in Danaher Corporation's own proxy. As printed: 23,795,280. Filing ↗machine: t122 · r2 · c21 · span 1070180–1070190 |
| 29 | Stryker Corporation, Section 10b CEO total | DEF 14A | 2026-03-23 | 0000310764-26-000013 | CEO total compensation as printed in Stryker Corporation's own proxy. As printed: 21,401,495. Filing ↗machine: t101 · r2 · c7 · span 1584979–1584989 |
| 30 | 3M Company, Section 10b CEO total | DEF 14A | 2026-03-25 | 0000066740-26-000151 | CEO total compensation as printed in 3M Company's own proxy. As printed: 21,005,009. Filing ↗machine: r2 · c9 · span 2797692–2797702 |
| 31 | Honeywell International Inc., Section 10b CEO total | DEF 14A | 2026-04-10 | 0000773840-26-000029 | CEO total compensation as printed in Honeywell International Inc.'s own proxy. As printed: 20,381,435. Filing ↗machine: span 2093429–2093439 |
| 32 | GE HealthCare Technologies Inc., Section 10b CEO total | DEF 14A | 2026-03-19 | 0001932393-26-000021 | CEO total compensation as printed in GE HealthCare Technologies Inc.'s own proxy. As printed: 18,562,794. Filing ↗machine: r3 · c39 · span 924977–924987 |
| 33 | Becton, Dickinson and Company, Section 10b CEO total | DEF 14A | 2025-12-18 | 0001628280-25-057846 | CEO total compensation as printed in Becton, Dickinson and Company's own proxy. As printed: 17,129,140. Filing ↗machine: r2 · c27 · span 1173285–1173295 |
| 34 | Colgate-Palmolive Company, Section 10b CEO total | DEF 14A | 2026-03-25 | 0001308179-26-000136 | CEO total compensation as printed in Colgate-Palmolive Company's own proxy. As printed: 16,478,196. Filing ↗machine: t137 · r1 · c18 · span 723853–723863 |
| 35 | Kimberly-Clark Corporation, Section 10b CEO total | DEF 14A | 2026-03-23 | 0001628280-26-020404 | CEO total compensation as printed in Kimberly-Clark Corporation's own proxy. As printed: 15,320,405. Filing ↗machine: r2 · c21 · span 1086894–1086904 |
| 36 | Illinois Tool Works, Inc., Section 10b CEO total | DEF 14A | 2026-03-27 | 0001193125-26-127599 | CEO total compensation as printed in Illinois Tool Works, Inc.'s own proxy. As printed: 15,211,011. Filing ↗machine: span 1647874–1647884 |
| 37 | Henry Schein, Inc., Section 10b CEO total | DEF 14A | 2026-04-08 | 0001193125-26-146317 | CEO total compensation as printed in Henry Schein, Inc.'s own proxy. As printed: 12,013,915. Filing ↗machine: t221 · r3 · c35 · span 671366–671376 |
| 38 | W.W. Grainger, Inc., Section 10b CEO total | DEF 14A | 2026-03-10 | 0001104659-26-025575 | CEO total compensation as printed in W.W. Grainger, Inc.'s own proxy. As printed: 11,609,508. Filing ↗machine: r1 · c32 · span 1578498–1578509 |
| 39 | Medline (subject), Section 10b CEO total | DEF 14A | 2026-04-23 | 0001104659-26-047092 | CEO total compensation as printed in Medline's own proxy. As printed: 3,860,972. Filing ↗machine: r1 · c42 · span 1422792–1422801 |
| 40 | Section 10a, Baxter International Inc. reciprocity | DEF 14A | — | 0001628280-26-020330 | Baxter International Inc.'s most recent proxy was read; its disclosed peer group does not include Medline. Filing ↗ |
| 41 | Section 10a, W.W. Grainger, Inc. reciprocity | DEF 14A | — | 0001104659-26-025575 | W.W. Grainger, Inc.'s most recent proxy was read; its disclosed peer group does not include Medline. Filing ↗ |
| 42 | Section 10a, Stryker Corporation reciprocity | DEF 14A | — | 0000310764-26-000013 | Stryker Corporation's most recent proxy was read; its disclosed peer group does not include Medline. Filing ↗ |
| 43 | Section 10a, 3M Company reciprocity | DEF 14A | — | 0000066740-26-000151 | 3M Company's most recent proxy was read; its disclosed peer group does not include Medline. Filing ↗ |
| 44 | Section 10a, GE HealthCare Technologies Inc. reciprocity | DEF 14A | — | 0001932393-26-000021 | GE HealthCare Technologies Inc.'s most recent proxy was read; its disclosed peer group does not include Medline. Filing ↗ |
| 45 | Section 10a, Honeywell International Inc. reciprocity | DEF 14A | — | 0000773840-26-000029 | Honeywell International Inc.'s most recent proxy was read; its disclosed peer group does not include Medline. Filing ↗ |
| 46 | Section 10a, Henry Schein, Inc. reciprocity | DEF 14A | — | 0001193125-26-146317 | Henry Schein, Inc.'s most recent proxy was read; its disclosed peer group does not include Medline. Filing ↗ |
| 47 | Section 10a, Becton, Dickinson and Company reciprocity | DEF 14A | — | 0001628280-25-057846 | Becton, Dickinson and Company's most recent proxy was read; its disclosed peer group does not include Medline. Filing ↗ |
| 48 | Section 10a, Danaher Corporation reciprocity | DEF 14A | — | 0000313616-26-000101 | Danaher Corporation's most recent proxy was read; its disclosed peer group does not include Medline. Filing ↗ |
| 49 | Section 10a, Illinois Tool Works, Inc. reciprocity | DEF 14A | — | 0001193125-26-127599 | Illinois Tool Works, Inc.'s most recent proxy was read; its disclosed peer group does not include Medline. Filing ↗ |